Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1390864
PUBLISHER: IMARC | PRODUCT CODE: 1390864
Formulation Development Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 138 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
The global formulation development outsourcing market size reached US$ 22.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.89% during 2022-2028.
Formulation development refers to the process of determining patentability, lifecycle, and the success of the pharmaceutical product. It also involves pre-formulation, including analytical assay development and characterization, excipient screening to stabilize or enhance the solubility of the product and dosage form development. It is often outsourced due to time pressure and a lack of internal resources. Formulation development outsourcing also offers numerous benefits, such as compressing timelines, accessing expertise, and providing extra insurance against product failure.
Formulation Development Outsourcing Market Trends:
The growing prevalence of chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, asthma, arthritis, and Alzheimer's disease, is catalyzing the demand for the discovery and development of new drugs. This, in turn, represents one of the key factors resulting in the formulation development services being outsourced to contract research organizations (CROs) around the world. Besides this, there is a rise in the need to overcome the risk and save time and money involved in passing the drug through the development pipeline. As a result, leading pharmaceutical and biotechnological companies worldwide are partnering with outsourcing services in the early phases of the drug development process. This, along with a significant increase in the need to innovate novel drugs on account of the rising patent expirations of major drugs, is contributing to market growth. Furthermore, expanding healthcare expenditure by business enterprises and governing agencies of several countries is creating a favorable market outlook. Moreover, the coronavirus disease (COVID-19) outbreak has positively influenced the need for clinical trials to find an effective treatment against the contagious infection. This has resulted in extensive investments in research and development (R&D) to develop therapeutics, which is projected to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global formulation development outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, dosage form, application and end user.
Breakup by Service:
Pre-formulation Services
Discovery and Preclinical Services
Analytical Services
Formulation Optimization
Phase I
Phase II
Phase III
Phase IV
Breakup by Dosage Form:
Injectable
Oral
Topical
Others
Breakup by Application:
Oncology
Genetic Disorders
Neurology
Infectious Diseases
Respiratory
Cardiovascular
Others
Breakup by End User:
Pharmaceutical and Biopharmaceutical Companies
Government and Academic Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy's Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global formulation development outsourcing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global formulation development outsourcing market?
- What are the key regional markets?
- What is the breakup of the market based on the service?
- What is the breakup of the market based on the dosage form?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global formulation development outsourcing market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A4747
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Formulation Development Outsourcing Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Service
- 6.1 Pre-formulation Services
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Discovery and Preclinical Services
- 6.1.2.2 Analytical Services
- 6.1.3 Market Forecast
- 6.2 Formulation Optimization
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Phase I
- 6.2.2.2 Phase II
- 6.2.2.3 Phase III
- 6.2.2.4 Phase IV
- 6.2.3 Market Forecast
7 Market Breakup by Dosage Form
- 7.1 Injectable
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Oral
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Topical
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Oncology
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Genetic Disorders
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Neurology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Infectious Diseases
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Respiratory
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Cardiovascular
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
9 Market Breakup by End User
- 9.1 Pharmaceutical and Biopharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Government and Academic Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Aizant Drug Research Solutions Private Limited
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Catalent Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Charles River Laboratories
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Dr. Reddy's Laboratories Ltd.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Emergent BioSolutions Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Intertek Group plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Irisys LLC (Recro Pharma)
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Laboratory Corporation of America Holdings
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Lonza Group AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Piramal Pharma Solutions
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.11 Quotient Sciences
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 Syngene International Limited (Biocon Limited)
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.13 Thermo Fisher Scientific Inc.
- 15.3.13.1 Company Overview
- 15.3.13.2 Product Portfolio
- 15.3.13.3 Financials
- 15.3.13.4 SWOT Analysis
- 15.3.1 Aizant Drug Research Solutions Private Limited
Product Code: SR112023A4747
List of Figures
- Figure 1: Global: Formulation Development Outsourcing Market: Major Drivers and Challenges
- Figure 2: Global: Formulation Development Outsourcing Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Formulation Development Outsourcing Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Formulation Development Outsourcing Market: Breakup by Service (in %), 2022
- Figure 5: Global: Formulation Development Outsourcing Market: Breakup by Dosage Form (in %), 2022
- Figure 6: Global: Formulation Development Outsourcing Market: Breakup by Application (in %), 2022
- Figure 7: Global: Formulation Development Outsourcing Market: Breakup by End User (in %), 2022
- Figure 8: Global: Formulation Development Outsourcing Market: Breakup by Region (in %), 2022
- Figure 9: Global: Formulation Development Outsourcing (Pre-formulation Services) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Formulation Development Outsourcing (Pre-formulation Services) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Formulation Development Outsourcing (Formulation Optimization) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Formulation Development Outsourcing (Formulation Optimization) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Formulation Development Outsourcing (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Formulation Development Outsourcing (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Formulation Development Outsourcing (Oral) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Formulation Development Outsourcing (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Formulation Development Outsourcing (Topical) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Formulation Development Outsourcing (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Formulation Development Outsourcing (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Formulation Development Outsourcing (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Formulation Development Outsourcing (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Formulation Development Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Formulation Development Outsourcing (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Formulation Development Outsourcing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Formulation Development Outsourcing (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Formulation Development Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Formulation Development Outsourcing (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Formulation Development Outsourcing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Formulation Development Outsourcing (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Formulation Development Outsourcing (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: Global: Formulation Development Outsourcing (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: Global: Formulation Development Outsourcing (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Global: Formulation Development Outsourcing (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Global: Formulation Development Outsourcing (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: North America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: North America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: United States: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: United States: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: Canada: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: Canada: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Asia-Pacific: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Asia-Pacific: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: China: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: China: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Japan: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Japan: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: India: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: India: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: South Korea: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: South Korea: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Australia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Australia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: Indonesia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: Indonesia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Europe: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Europe: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Germany: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Germany: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: France: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: France: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: United Kingdom: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: United Kingdom: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Italy: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Italy: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Spain: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Spain: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Russia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Russia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Latin America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Latin America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 79: Brazil: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 80: Brazil: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Mexico: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 82: Mexico: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 83: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 84: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 85: Middle East and Africa: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
- Figure 86: Middle East and Africa: Formulation Development Outsourcing Market: Breakup by Country (in %), 2022
- Figure 87: Middle East and Africa: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 88: Global: Formulation Development Outsourcing Industry: SWOT Analysis
- Figure 89: Global: Formulation Development Outsourcing Industry: Value Chain Analysis
- Figure 90: Global: Formulation Development Outsourcing Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Formulation Development Outsourcing Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Formulation Development Outsourcing Market Forecast: Breakup by Service (in Million US$), 2023-2028
- Table 3: Global: Formulation Development Outsourcing Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
- Table 4: Global: Formulation Development Outsourcing Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 5: Global: Formulation Development Outsourcing Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Formulation Development Outsourcing Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Formulation Development Outsourcing Market: Competitive Structure
- Table 8: Global: Formulation Development Outsourcing Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.